| 注册
首页|期刊导航|中国药物评价|北京急救中心院前急救药品应用情况分析

北京急救中心院前急救药品应用情况分析

刘恬恬 贾存秋 胡静 吴易丛 陈珊珊

中国药物评价2024,Vol.41Issue(3):248-250,3.
中国药物评价2024,Vol.41Issue(3):248-250,3.

北京急救中心院前急救药品应用情况分析

Utilization Analysis of Pre-hospital Emergency Medicines in Beijing Emergency Medical Center

刘恬恬 1贾存秋 1胡静 1吴易丛 1陈珊珊1

作者信息

  • 1. 北京急救中心药械科,北京 100031
  • 折叠

摘要

Abstract

Objective:To analyze the usage of pre-hospital emergency drugs in Beijing Emergency Center in 2022,providing reference basis for rational medication in pre-hospital emergency care.Methods:From January 2022 to December 2022,the varieties,sales a-mount,and frequency of pre-hospital emergency drugs used in Beijing Emergency Center were statistically analyzed using the defined daily dose(DDD)method.Results:The top three drugs with the highest frequency of usage were Epinphrine Hydrochloride Injection,Xingnao-jing Injection,and Urapidil Hydrochloride Injection.With the first three highest cost of treatment were Shenfu Injection,Xingnaojing In-jection,and Urapidil Hydrochloride Injection.Conclusion:The usage of pre-hospital emergency drugs in the hospital is generally reason-able,with antishock vasoactive drugs,antihypertensive drugs accounting for the majority in the hospital.Subsequent rational procurement and supply should be based on clinical use.

关键词

院前急救药品/用药频度/用药分析/合理用药

Key words

Pre-hospital emergency medicines/Medication frequency/Medication analysis/Rational drug use

分类

医药卫生

引用本文复制引用

刘恬恬,贾存秋,胡静,吴易丛,陈珊珊..北京急救中心院前急救药品应用情况分析[J].中国药物评价,2024,41(3):248-250,3.

中国药物评价

2095-3593

访问量0
|
下载量0
段落导航相关论文